Lulenorm Cream
General Range

Lulenorm Cream

Enorm Med Pharma Pvt. Ltd.Panchkula, Haryana

Price on request/100 · MOQ 100 boxes

Lulenorm Cream by Enormmed Pharma Private Limited is a topical antifungal formulation containing Luliconazole 1% w/w, used for the treatment of certain fungal skin infections caused by susceptible dermatophytes.

Luliconazole belongs to the imidazole class of antifungal medicines. It works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes. This action disrupts fungal cell membrane formation and helps control the growth of infection-causing fungi.

Lulenorm Cream may be prescribed for common fungal skin infections, including ringworm (Tinea Corporis), jock itch (Tinea Cruris) and athlete's foot (Tinea Pedis). It helps treat the underlying fungal infection, allowing symptoms such as itching, redness, scaling and irritation to improve as the infection resolves.

Available in a 50 gm tube, Lulenorm Cream is intended for external application only. The frequency and duration of use should follow the product label or a healthcare professional's instructions.

CategoryGeneral Range
Min. Order100 boxes
Supplied byEnorm Med Pharma Pvt. Ltd.
CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition
Luliconazole Cream 1% w/w
Packaging Type
Topical Cream
Packaging Size
50 gm
Dosage Form
Cream
Treatment
Itching and Redness: Helps reduce symptoms associated with fungal infections as the infection resolves.
Shelf Life
24 Months
Storage
Store below 30°C, protect from light & moisture
Certification
WHO-GMP, ISO

Company Info

Enorm Med Pharma Pvt. Ltd.Panchkula, Haryana
View Full Profile

Enorm Med Pharma Private Limited is an Indian pharmaceutical company based in Panchkula, Haryana, specializing in the manufacture, trade, wholesale, and export of a wide range of pharmaceutical formulations.

Company Overview

• Incorporation / Establishment: Originally started as a proprietorship in 2021, later incorporated as a private limited company on April 9, 2023 (CIN: U46497HR2023PTC110540).
• Registered Address: SCO 272, Sector-20, Panchkula, Haryana – 134116, India.
• Directors / Leadership: Sukhinder Jindal and Gurpreet Jindal.
• Certifications: ISO 9001:2015 and WHO-GMP compliant operations/standards.
• Business Model: PCD (Propaganda Cum Distribution) Pharma Franchise, third-party manufacturing, wholesale distribution, and domestic/global supply.

Product Portfolio

Enorm Med Pharma deals in diverse therapeutic segments and dosage forms, including:
• Dosage Forms: Tablets, capsules, softgelatin capsules, syrups, dry syrups, injections (vials), and ointments.
• Therapeutic Ranges: Anti-infectives, cardiac, diabetic, dermatology, and general wellness/herbal formulas.
• Notable Branded Products: Azeenorm (Azithromycin), Diclonorm, Enomzole-D, Levonorm, Pantenorm, Norsunate (Artesunate injections), and Mebenorm.

More General Range